Cargando…
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December 2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up extraordinary challenges. This unprecedented situation led to the inception of numerous fundamental research protocols and...
Autores principales: | Jamilloux, Yvan, Henry, Thomas, Belot, Alexandre, Viel, Sébastien, Fauter, Maxime, El Jammal, Thomas, Walzer, Thierry, François, Bruno, Sève, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196557/ https://www.ncbi.nlm.nih.gov/pubmed/32376392 http://dx.doi.org/10.1016/j.autrev.2020.102567 |
Ejemplares similares
-
Diagnosing Hemophagocytic Lymphohistiocytosis with Machine Learning: A Proof of Concept
por: El Jammal, Thomas, et al.
Publicado: (2022) -
Low glycosylated ferritin is a sensitive biomarker of severe COVID-19
por: Fauter, Maxime, et al.
Publicado: (2020) -
Extreme Hyperferritinemia: Causes and Prognosis
por: Fauter, Maxime, et al.
Publicado: (2022) -
Intravenous anakinra for cytokine storm syndromes
por: Jamilloux, Yvan, et al.
Publicado: (2020) -
Diagnostic value of elevated serum angiotensin-converting enzyme and lymphopenia in patients with granulomatous hepatitis
por: El Jammal, Thomas, et al.
Publicado: (2023)